Healthcare

FDA approves RSV preventative injection for infants

By Gabrielle M. Etzel
Published July 17, 2023 6:45pm ET
Add Washington Examiner on Google
FDA approves RSV preventative injection for infants
The Food and Drug Administration announced on Monday it has given full approval for a new preventative injection for infants under age 2 to protect them from contracting respiratory syncytial virus, or RSV. The fast-track approval of AstaZeneca’s Beyfortus comes less than one year after the so-called “tripledemic” of influenza, COVID-19, and RSV put many […]

The Food and Drug Administration announced on Monday it has given full approval for a new preventative injection for infants under age 2 to protect them from contracting respiratory syncytial virus, or RSV.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Children FDA Infectious Disease